relapse prevention

Advertisement

cGxPJobs Banner

Johnson & Johnson Strengthens CNS Portfolio with CAPLYTA FDA Nod

TITUSVILLE, NEW JERSEY, April 27, 2026 Johnson & Johnson has received U.S. Food and Drug Administration (FDA) approval for...

By cGxPwire Editor
April 28, 2026

Read More

Advertisement

cGxPJobs

Directory